We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$2.74B
AUM Growth
+$784M
Cap. Flow
+$747M
Cap. Flow %
27.2%
Top 10 Hldgs %
48.94%
Holding
625
New
262
Increased
87
Reduced
48
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 38.11%
2 Healthcare 11.13%
3 Financials 10.69%
4 Communication Services 6.18%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCY icon
351
Incyte
INCY
$23.5B
$256K 0.01%
+3,019
New +$242K
JEF icon
352
Jefferies Financial Group
JEF
$12.9B
$250K 0.01%
14,533
HPE icon
353
Hewlett Packard
HPE
$63.2B
$241K 0.01%
16,133
-17,574
-52% -$266K
RF icon
354
Regions Financial
RF
$26.3B
$241K 0.01%
16,118
-5,586
-26% -$82.5K
CHTR icon
355
Charter Communications
CHTR
$14.7B
$236K 0.01%
+598
New +$224K
EL icon
356
Estee Lauder
EL
$29B
$235K 0.01%
+1,283
New +$219K
KEY icon
357
KeyCorp
KEY
$24.3B
$230K 0.01%
12,932
-27,753
-68% -$469K
CME icon
358
CME Group
CME
$92.2B
$220K 0.01%
1,133
-3,146
-74% -$580K
UBS icon
359
UBS Group
UBS
$170B
$217K 0.01%
+18,243
New +$224K
ENDP
360
DELISTED
Endo International plc
ENDP
$162K 0.01%
+39,287
New +$248K
SWN
361
DELISTED
Southwestern Energy Company
SWN
$153K 0.01%
48,378
-59,998
-55% -$233K
GCI
362
DELISTED
Gannett Co., Inc
GCI
$129K ﹤0.01%
15,749
CRD.B icon
363
Crawford & Co Class B
CRD.B
$493M
$110K ﹤0.01%
+11,854
New +$104K
DRRX
364
DELISTED
DURECT Corp
DRRX
$110K ﹤0.01%
+16,856
New +$105K
BLCM
365
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$109K ﹤0.01%
+6,384
New +$173K
HBIO icon
366
Harvard Bioscience
HBIO
$27.1M
$97K ﹤0.01%
+4,844
New +$142K
GYRE icon
367
Gyre Therapeutics
GYRE
$662M
$94K ﹤0.01%
+1,704
New +$106K
LTHM
368
DELISTED
Livent Corporation
LTHM
$75K ﹤0.01%
10,799
KOPN icon
369
Kopin
KOPN
$663M
$69K ﹤0.01%
+63,533
New +$77.3K
TTOO
370
DELISTED
T2 Biosystems, Inc
TTOO
$69K ﹤0.01%
+8
New +$93.7K
AGFS
371
DELISTED
AgroFresh Solutions Inc
AGFS
$63K ﹤0.01%
+41,949
New +$110K
ABUS icon
372
Arbutus Biopharma
ABUS
$865M
$61K ﹤0.01%
+29,104
New +$74.5K
INAP
373
DELISTED
Internap Corporation
INAP
$60K ﹤0.01%
+19,983
New +$71.1K
VSTM icon
374
Verastem
VSTM
$532M
$59K ﹤0.01%
+3,267
New +$74K
TPHS
375
DELISTED
Trinity Place Holdings Inc.com
TPHS
$57K ﹤0.01%
+14,459
New +$59K

Similar funds

LMR Partners's Q2 2019 Portfolio in Review

As of Q2 2019, LMR Partners held 625 positions worth $2.74B, up 40% from $1.96B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

LMR Partners deployed $747M of net new capital in Q2 2019, opening 262 new positions and adding to 87 existing holdings. Its largest new stake was Infosys: 8,074,345 shares worth $86.4M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was TSMC, an estimated $132M trimmed.

  • LMR Partners's largest Q2 2019 buy was Infosys: 8,074,345 shares worth $86.4M.
  • LMR Partners added most to Altaba Inc in Q2 2019, an estimated $194M increase.
  • LMR Partners's biggest Q2 2019 reduction was TSMC, cutting an estimated $132M.
  • LMR Partners fully exited HSBC in Q2 2019, selling an estimated $83.1M.
  • LMR Partners's ten largest holdings make up 49% of its $2.74B portfolio in Q2 2019.
  • LMR Partners opened 262 new positions and closed 207 in Q2 2019.
  • LMR Partners's portfolio value rose 40% quarter-over-quarter to $2.74B.

Based on LMR Partners's 13F filing for Q2 2019, filed 14 Aug 2019.